Richard Barasch - Nov 12, 2021 Form 4/A - Amendment Insider Report for Oncology Institute, Inc. (TOI)

Role: Director
Signature: By: /s/ Mark Hueppelsheuser, Attorney-in-Fact for Richard Barasch
Stock symbol: TOI
Transactions as of: Nov 12, 2021
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 11/18/2021, 07:22 PM
Date Of Original Report: Nov 16, 2021
Previous filing: Aug 25, 2021
Next filing: Nov 18, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TOI	Common Stock	Options Exercise		+100K			100K	Nov 12, 2021	Direct	F1, F2
transaction	TOI	Common Stock	Disposed to Issuer		-14.9K	-14.89%		85.1K	Nov 12, 2021	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TOI	Class B Common Stock	Options Exercise		-100K	-100%		0	Nov 12, 2021	Class A Common Stock	100K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as defined below), and have no expiration date.
F2	On November 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as June 28, 2021, by and among DFP Healthcare Acquisitions Corp. ("DFP"), Orion Merger Sub I, Inc. ("First Merger Sub"), Orion Merger Sub II, LLC ("Second Merger Sub"), and TOI Parent, Inc. ("Old TOI"), First Merger Sub merged into Old TOI, with Old TOI being the surviving corporation then Old TOI merged into Second Merger Sub, with Second Merger Sub being the surviving entity and a wholly owned subsidiary of DFP, which then changed its name to The Oncology Institute, Inc. (such transactions, collectively, the "Business Combination"). In connection with the Business Combination, the Class A common stock was converted to Common Stock of the Issuer, pursuant to a reclassification exempt under Rule 16b-7.
F3	On November 12, 2021, in connection with the Business Combination, Mr. Barasch, forfeited 14,887 of his shares of the Issuer's common stock to the Issuer pursuant to the Stockholder Support Agreement, dated as of June 28, 2021, by and among, DFP And TOI and certain DFP directors and officers, including Mr. Barasch.

Remarks:

This amendment restates the Form 4 filed on 11/16/2021 in order to correct the transaction code for the conversion of Class B common stock to common stock to reflect that it is an exempt conversion pursuant to Rule 16b-3 and to add footnote 3.